NC
GRTS

NinePointTwo Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

NinePointTwo Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-71,619
Closed -$295K – 272
2022
Q1 		$295K Buy
+71,619
New +$379K 0.08% 121

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

NinePointTwo Capital's GRTS Position: Q2 2022 in Review

NinePointTwo Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 71,619 shares — an estimated $295K sold.

NinePointTwo Capital first reported a position in GRTS in Q1 2022 and held it in 1 quarter. The position peaked at $295K in Q1 2022. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • NinePointTwo Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 71,619 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $295K.
  • NinePointTwo Capital first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • NinePointTwo Capital's Gritstone bio, Inc. Common Stock position peaked at $295K in Q1 2022.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on NinePointTwo Capital's 13F filing for Q2 2022, filed 15 Aug 2022.